| Adverse event . | Grade 1/2 . | Grade 3/4 . | Total n (%) . |
|---|---|---|---|
| Injection site reaction/Rash (maculopapular) | 47 (98) | 0 | 47 (98) |
| Myalgia | 27 (56) | 0 | 27 (56) |
| Fever | 22 (46) | 0 | 22 (46) |
| Fatigue | 22 (46) | 0 | 22 (46) |
| Chills | 21 (44) | 0 | 21 (44) |
| Hematologic | |||
| Neutropenia | 8 (17) | 8 (17) | 18 (38) |
| Thrombocytopenia | 13 (27) | 0 | 13 (27) |
| Anemia | 1 (2) | 0 | 1 (2) |
| Pain (local site) | 17 (35) | 0 | 17 (35) |
| Arthralgia | 16 (33) | 0 | 16 (33) |
| Headache | 15 (31) | 0 | 15 (31) |
| Pruritus | 13 (27) | 0 | 13 (27) |
| Diarrhea | 3 (6) | 0 | 3 (6) |
| Insomnia | 2 (4) | 0 | 2 (4) |
| Anorexia | 2 (4) | 0 | 2 (4) |
| Vomiting | 2 (4) | 0 | 2 (4) |
| Nausea | 2 (4) | 0 | 2 (4) |
| Neutropenic fever | 0 | 1 (2) | 1 (2) |
| Adverse event . | Grade 1/2 . | Grade 3/4 . | Total n (%) . |
|---|---|---|---|
| Injection site reaction/Rash (maculopapular) | 47 (98) | 0 | 47 (98) |
| Myalgia | 27 (56) | 0 | 27 (56) |
| Fever | 22 (46) | 0 | 22 (46) |
| Fatigue | 22 (46) | 0 | 22 (46) |
| Chills | 21 (44) | 0 | 21 (44) |
| Hematologic | |||
| Neutropenia | 8 (17) | 8 (17) | 18 (38) |
| Thrombocytopenia | 13 (27) | 0 | 13 (27) |
| Anemia | 1 (2) | 0 | 1 (2) |
| Pain (local site) | 17 (35) | 0 | 17 (35) |
| Arthralgia | 16 (33) | 0 | 16 (33) |
| Headache | 15 (31) | 0 | 15 (31) |
| Pruritus | 13 (27) | 0 | 13 (27) |
| Diarrhea | 3 (6) | 0 | 3 (6) |
| Insomnia | 2 (4) | 0 | 2 (4) |
| Anorexia | 2 (4) | 0 | 2 (4) |
| Vomiting | 2 (4) | 0 | 2 (4) |
| Nausea | 2 (4) | 0 | 2 (4) |
| Neutropenic fever | 0 | 1 (2) | 1 (2) |
Data are presented as n (%) unless specified otherwise.